Fortitude Family Office’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Fortitude Family Office's HALO Position: Q2 2026 in Review
Fortitude Family Office increased its Halozyme (HALO) stake by 45% in Q2 2026, buying an estimated $1.23K and bringing the position to 58 shares worth $4.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1126.
Fortitude Family Office first reported a position in HALO in Q3 2024 and has held it in 7 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Fortitude Family Office held 58 shares of Halozyme worth $4.54K as of Q2 2026.
- Fortitude Family Office bought 18 Halozyme shares in Q2 2026, an estimated $1.23K.
- Halozyme made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1126 holding.
- Fortitude Family Office first reported a position in Halozyme in Q3 2024 and has held it in 7 quarters since.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.